Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that ADMA Biologics, Inc. made materially false and/or misleading statements and/or failed to disclose that: On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. The news caused a precipitous decline in the price of ADMA Biologics stock. ADMA Biologics stock price fell over 20% on October 10, 2024.
In order to be eligible to join the ADMA class action lawsuit, you must have incurred a loss on shares of ADMA Biologics, Inc. purchased during the class period listed above.
TOP
